Aardvark Therapeutics (AARD) shares debuted on Nasdaq Thursday with an opening price of $15.18, below the initial public offering price of $16.
The shares more recently were changing hands at roughly $14 apiece, further down 13%.
The stock debuted on the Nasdaq Global Market under the ticker symbol "AARD."
The IPO consists of 5.9 million shares to raise $94.2 million and the company has granted underwriters an option to buy up to an additional 883,200 shares.
Price: 13.87, Change: -2.13, Percent Change: -13.31
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.